Milestone Scientific Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Milestone Scientific Inc 's ROA in the second quarter of 2026?
Milestone Scientific Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -50.84%.

However, within the Healthcare sector 569 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3997, from total ROA ranking in the first quarter of 2026 at 4784.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	3.69 %	-12.38 %	-20.32 %	-24.06 %	-32.94 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-4	-5	-6	-7	-7
Return On Assets (TTM)	-50.84 %	-56.55 %	-68.47 %	-75.29 %	-73.2 %
MLSS's Total Ranking	# 3997	# 4784	# 4246	# 4287	# 4155
Total Assets (TTM) in million	8	8	8	8	8
Seq. Total Assets Change	4.83 %	2.01 %	-8.01 %	5.41 %	-11.41 %
Seq. Net Income Change	-	-	-	-	-

MLSS's 5 Years Annual ROA >> Back to MLSS Management Effectiveness >> Compare MLSS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 142
Sector	# 570
Overall	# 3903

Return On Assets Statistics
High	Average	Low
24.75 %	-46.06 %	-129.42 %
(Dec 31 2013)		(Mar 31 2020)

News about Milestone Scientific Inc Return on Assets ROA

Milestone Scientific Navigates New Horizons: Leadership Transition Coincides with Groundbreaking Innovations in Pain Management,

Milestone Scientific Inc. a leading player in the field of computerized drug delivery instruments, has announced a significant leadership transition that marks the end of an era as CEO Arjan Haverhals prepares for retirement. Effective December 31, 2024, Haverhals will step down from his role as chief executive officer but will continue to serve the company as a board director, providing consulting services to ensure continuity during this pivotal transition. Neal Goldman, the company’s chairman, will take on the role of interim CEO. A Changing of the GuardThe retirement of Haverhals comes at a time when Milestone Scientific faces both challenges and opportunities. Under his leadership, Milestone has worked to enhance its position in the medical industry with its innovative technologies, including the CompuFlo Epidural System, which has recently been introduced at iHeal Pain Center. While Haverhals’ impending departure signals a new chapter for the company, it also represents a period of uncertainty. After recording a cumulative net loss of $5 million during the 12 months ending in the second quarter of 2024 alongside a negative return on assets (ROA) of -41.05%, stakeholders are looking toward future leadership to navigate the company’s financial hurdles.

Revolutionizing Pain Management Milestone Scientifics CompuFlo Epidural System Launches at iHeal, Backed ...

Milestone Scientific Inc. recently announced an exciting development in the medical field with the commercial rollout of its advanced CompuFlo Epidural System at iHeal Pain Center. This groundbreaking system promises to revolutionize how epidural analgesia is administered, enhancing the safety and efficacy of pain management treatments. The decision to introduce the CompuFlo Epidural System at iHeal not only signifies a strategic milestone for Milestone Scientific but also reflects a wider commitment to improving patient outcomes in pain management. Enhancing the Epidural Procedure with CompuFlo TechnologyThe CompuFlo Epidural System stands out in the medical community due to its innovative use of computer-controlled technology that precisely identifies the epidural space using real-time pressure sensing. This ensures that clinicians can administer medications effectively and reduces the risks often associated with traditional methods. By offering higher accuracy in targeting the epidural space, the CompuFlo system enhances patient safety and minimizes the risk of complications including the potential for dural puncture.

Financial Statements
Milestone Scientific Inc 's Assets	$ 8 million	MLSS's Balance sheet
Milestone Scientific Inc 's Income	$ -1 million	Quarterly MLSS's Income Statement
MLSS's Income by Division		See MLSS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-20.32 %	-13.85 %	-17.01 %	-30.83 %	1.22 %
Total Assets in million	8	10	11	14	20
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-6	-5	-7	-9	-7
Annual Return On Assets	-73.3 %	-48.11 %	-61.39 %	-64.03 %	-34.71 %

MLSS's 5 Years Annual ROA >> Back to MLSS Management Effectiveness >> Compare MLSS ROA to its Competitors

More Return On Assets Ratios
MLSS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MLSS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MLSS's Competitors
Subscribers only: Roa for Milestone Scientific Inc 's Suppliers
Subscribers only: Return On Assets for MLSS's Customers

You may also want to know
MLSS's Roi	MLSS's Inventory Turnover Ratio	MLSS's Growth Rates	MLSS's Dividend Comparisons
	MLSS's Profitability Ratios	MLSS's Asset Turnover Ratio	MLSS's Dividend Growth
MLSS's Roe	MLSS's Valuation Ratios	MLSS's Financial Strength Ratios	MLSS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T18:59:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.